Frostbite involving multiple body regions and unspecified frostbite

ST19_FROST_INVOLVI_MULTIPLE_BODY_REGIONS_UNSPE_FROST

No definition available.

Endpoint definition

↥

Report an error or suggest an improvement for this endpoint codes

Endpoint definition steps	FinnGen
Phenotype data	520210
1. Apply sex-specific rule None	520210
2. Check conditions None	520210
3. Check pre-conditions, main-only, mode, registry filters Registry filters: Hospital discharge: ICD-10 — T35 Cause of death: ICD-10 — T35 2 out of 7 registries used, show all original rules.	76
4. Check minimum number of events None	76
5. Include endpoints None	76
6. Filter based on genotype QC (FinnGen only)	76

Control definitions (FinnGen only)

Control exclude: ST19_FROSTBITE

Extra metadata

Level in the ICD hierarchy: 3
First used in FinnGen datafreeze: DF4
Parent code in ICD-10: T3[3-5]
Name in latin: Congelatio multarum regionum corporis sive non specificata

NAME	ST19_FROST_INVOLVI_MULTIPLE_BODY_REGIONS_UNSPE_FROST
CONTROL_EXCLUDE	ST19_FROSTBITE
CONTROL_PRECONDITIONS
CONTROL_CONDITIONS
SEX
INCLUDE
PRE_CONDITIONS
CONDITIONS
OUTPAT_ICD
OUTPAT_OPER
HD_MAINONLY
HD_ICD_10_ATC
HD_ICD_10	T35
HD_ICD_9
HD_ICD_8
HD_ICD_10_EXCL
HD_ICD_9_EXCL
HD_ICD_8_EXCL
COD_MAINONLY
COD_ICD_10	T35
COD_ICD_9
COD_ICD_8
COD_ICD_10_EXCL
COD_ICD_9_EXCL
COD_ICD_8_EXCL
OPER_NOM
OPER_HL
OPER_HP1
OPER_HP2
KELA_REIMB
KELA_REIMB_ICD
KELA_ATC_NEEDOTHER
KELA_ATC
KELA_VNRO_NEEDOTHER
KELA_VNRO
CANC_TOPO
CANC_TOPO_EXCL
CANC_MORPH
CANC_MORPH_EXCL
CANC_BEHAV

Similar endpoints

↥

List of similar endpoints to Frostbite involving multiple body regions and unspecified frostbite based on the number of shared cases.

Similar with more cases:

Similar with less cases:

None

Case counts by codes

↥

FinnGen case counts by registry codes:

Upset plot

Full data table

Summary Statistics

↥

-FinRegistry-

This endpoint is excluded from FinRegistry analyses (omitted endpoint).

-FinnGen-

Key figures

	All	Female	Male
Number of individuals	76	22	54
Unadjusted period prevalence (%)	0.02	0.01	0.02
Median age at first event (years)	53.85	57.81	52.24

-FinnGen-

Age distribution of first events

-FinnGen-

Year distribution of first events

-FinnGen-

Cumulative Incidence Function

Not a core endpoint, no data to show.

CodeWAS (R11)

↥

CodeWAS is a tool for exploring the associations between an endpoint and all of the medical codes and drug codes.

This is a new tool, please reach out using the contact form for feedback and improvement ideas.

First, a cohort is built by matching controls to the endpoint cases using year of birth and sex. Then, a Fisher test is done for all the medical codes and drug codes between the cases and controls of this cohort. Codes are reported in the table below if they have −log₁₀(p-value) ≥ 6.

Matched cohort

Matched cases
64: Matched controls
638

Code

Vocabulary

Description

Odds Ratio

-log₁₀(p)

N matched cases

N matched controls

X31

ICD-10 Finland

Exposure to excessive natural cold

+∞

30.7

T35.5

ICD-10 Finland

Unspecified frostbite of lower limb

+∞

24.5

T35.4

ICD-10 Finland

Unspecified frostbite of upper limb

+∞

19.8

F10.1

ICD-10 Finland

Mental and behavioural disorders due to use of alcohol, Harmful use

21.7

15.6

T68

ICD-10 Finland

Hypothermia

+∞

11.8

T35.0

ICD-10 Finland

Superficial frostbite involving multiple body regions

+∞

11.8

N07BB01

ATC

disulfiram; oral

23.9

10.9

F10.29

ICD-10 Finland

Addiction caused by alcohol UNS

40.0

10.8

NDQ20

NOMESCO Finland

Amputation of finger

+∞

8.5

R56.8

ICD-10 Finland

Other and unspecified convulsions

12.2

7.4

SPAT1148

SPAT

Treatment of chronic ulcer or burn

6.8

7.4

AA1AD

NOMESCO Finland

CT of head and brain

5.1

7.2

G72.8

ICD-10 Finland

Other specified myopathies

44.9

6.9

F10.20

ICD-10 Finland

Alcohol dependence currently independent

44.9

6.9

P15

ICPC

Chronic alcohol abuse

20.6

6.5

F10.2

ICD-10 Finland

Mental and behavioural disorders due to use of alcohol, Dependence syndrome

+∞

6.3

T33.5

ICD-10 Finland

Superficial frostbite of wrist and hand

+∞

6.3

F10.49

ICD-10 Finland

Withdrawal symptoms and delirium caused by alcohol without information about seizures

+∞

6.3

T35.7

ICD-10 Finland

Unspecified frostbite of unspecified site

+∞

6.3

X59

ICD-10 Finland

Exposure to unspecified factor

4.3

6.0

S97

ICPC

Chronic ulcer skin

12.9

6.0

LabWAS

↥

N Cases

N Controls

-log₁₀(p)

cases

controls

cases

controls

unit

-log₁₀(p)

N cases

N controls

(3003396) Base excess in Arterial blood by calculation

4.72

8.05

8.3

18.2

1.73

1.61

mmol/l

0.04

(3007220) Creatine kinase [Enzymatic activity/volume] in Serum or Plasma

174

3.37

6.33

3.9

2.4

1128.68

297.84

u/l

0.50

165

(3003031) Transferrin.carbohydrate deficient.disialo/Transferrin.total in Serum or Plasma

3.64

6.15

4.2

2.3

2.25

1.60

1.56

(3007853) Bacteria identified in Skin by Aerobe culture

3.63

5.18

2.8

1.4

—

(3023368) Bacteria identified in Blood by Culture

152

2.91

4.75

5.8

4.2

—

(3016293) Bicarbonate [Moles/volume] in Serum or Plasma

4.17

4.74

7.1

7.3

24.71

24.37

mmol/l

0.12

(3000991) Gas panel - Venous blood

3.35

3.51

11.0

8.6

—

(3019060) Gas panel - Arterial blood

3.66

3.51

4.3

18.9

—

(3019800) Troponin T.cardiac [Mass/volume] in Serum or Plasma

200

2.27

2.98

5.6

4.1

1064.34

37.05

ng/l

0.48

135

(3020891) Body temperature

4.83

2.88

7.0

6.9

—

(3026008) Bacteria identified in Urine by Culture

135

2.27

2.63

3.4

3.0

—

(3029937) Albumin [Presence] in Urine by Test strip

135

2.27

2.63

5.9

3.6

0.00

estimate

—

(3012544) pH of Venous blood

2.98

2.59

2.4

4.0

—

(3018677) aPTT in Platelet poor plasma by Coagulation assay

2.42

2.54

2.4

1.8

30.64

29.28

0.32

(3028707) Methadone [Presence] in Urine by Screen method

5.32

2.45

2.0

1.4

—

(42870588) Differential panel, method unspecified - Blood

191

2.05

2.31

4.5

5.9

—

(3042936) Bacteria identified in Isolate by Culture

2.44

2.28

3.6

2.3

—

(3016879) Cocaine [Presence] in Urine

3.60

2.25

2.9

1.4

—

(3021601) Nitrite [Presence] in Urine by Test strip

256

1.97

2.18

5.4

4.6

0.00

estimate

—

(3032080) INR in Blood by Coagulation assay

231

1.95

2.11

9.1

7.2

1.33

1.21

inr

0.30

(3038288) Influenza virus B RNA [Presence] in Specimen by NAA with probe detection

2.39

2.09

1.8

1.7

—

(3000764) Benzodiazepines [Presence] in Urine

3.31

2.08

2.9

1.3

—

(3028300) Cannabinoids [Presence] in Urine

3.31

2.08

2.9

1.4

—

(3027008) Opiates [Presence] in Urine

3.31

2.08

2.9

1.3

—

(3029287) Urinalysis microscopic panel [#/volume] - Urine by Automated count

206

1.96

2.07

2.9

2.7

—

(3016431) Calcium.ionized [Moles/volume] adjusted to pH 7.4 in Serum or Plasma

253

1.90

1.98

11.0

9.7

1.19

1.21

mmol/l

0.69

216

(40762366) Oxygen capacity [Volume Fraction] in Arterial blood

2.86

1.94

14.9

25.0

—

(3009261) Glucose [Presence] in Urine by Test strip

265

1.87

1.90

4.7

3.4

0.00

estimate

—

(40763086) Leukocyte esterase [Presence] in Urine by Automated test strip

194

1.90

1.88

5.4

3.6

—

(3016407) Fibrinogen [Mass/volume] in Platelet poor plasma by Coagulation assay

3.74

1.87

2.2

1.8

3.17

3.72

g/l

—

(3044640) Blood type and Crossmatch panel - Blood

169

1.93

1.86

2.7

2.5

—

(3019250) Coagulation factor VIII activity actual/normal in Platelet poor plasma by Coagulation assay

3.52

1.78

2.5

2.1

174.50

228.72

—

(3001079) Blood group antibody screen [Presence] in Serum or Plasma

269

1.83

1.78

5.1

4.5

—

(36031861) Influenza virus A and B and SARS-CoV-2 (COVID-19) and Respiratory syncytial virus RNA panel - Respiratory system specimen by NAA with probe detection

3.10

1.77

2.0

1.5

—

(1616796) Gas panel - Central venous blood

4.04

1.74

2.6

2.9

—

(3035350) Ketones [Presence] in Urine by Test strip

262

1.80

1.71

4.8

3.3

0.00

estimate

—

(1001926) Buprenorphine [Presence] in Urine by Screen method

3.34

1.69

3.2

1.3

—

(3011288) Drugs identified in Urine by Screen method

3.34

1.69

5.2

1.4

—

(3027944) Amphetamines [Presence] in Urine

2.98

1.69

3.1

1.4

—

(3021879) Hepatitis B virus core Ab [Presence] in Serum

2.40

1.66

1.4

1.8

—

(3011397) Hemoglobin [Presence] in Urine by Test strip

126

1.92

1.62

4.6

3.3

—

(44816559) Phosphatidylethanol [Mass/volume] in Blood

3.16

1.61

2.5

1.3

—

(3044938) Influenza virus A RNA [Presence] in Specimen by NAA with probe detection

2.02

1.59

2.0

1.7

—

(3013290) Carbon dioxide [Partial pressure] in Blood

3.49

1.55

4.0

2.5

4.82

5.33

kpa

—

(3027315) Oxygen [Partial pressure] in Blood

3.49

1.55

4.0

2.5

8.94

8.59

kpa

—

(3013650) Neutrophils [#/volume] in Blood by Automated count

335

1.74

1.54

11.2

10.8

4.22

4.09

e9/l

0.13

291

(3004119) Hemoglobin [Mass/volume] in Venous blood

2.65

1.49

3.1

4.9

142.71

120.71

g/l

—

(3043924) Respiratory syncytial virus RNA [Identifier] in Specimen by NAA with probe detection

2.13

1.49

2.0

1.6

—

(1761868) Lipid panel - Serum or Plasma

232

0.51

1.42

2.3

2.5

—

(3006315) Basophils [#/volume] in Blood

274

1.68

1.39

5.1

6.8

0.04

e9/l

0.32

243

(3045783) Sodium and Potassium panel [Moles/volume] - Serum or Plasma

2.07

1.38

15.7

8.3

—

(3027238) Thyroperoxidase Ab [Units/volume] in Serum or Plasma

0.00

1.38

0.0

1.1

—

117.77

—

(3019198) Lymphocytes [#/volume] in Blood

284

1.68

1.38

5.2

6.8

1.79

1.77

e9/l

0.06

256

(3001604) Monocytes [#/volume] in Blood

275

1.67

1.37

5.1

6.7

0.63

0.59

e9/l

0.42

242

(40761536) Microorganisms panel - Urine sediment

2.18

1.32

3.2

3.6

—

(3010517) Carboxyhemoglobin/Hemoglobin.total in Venous blood

2.52

1.27

3.5

2.6

1.28

1.36

—

(3009508) Creatinine [Moles/volume] in Urine

153

1.72

1.26

2.5

3.1

8.71

7.78

mmol/l

0.36

134

(3051552) Clostridioides difficile toxin genes [Presence] in Stool by NAA with probe detection

2.30

1.26

2.4

1.6

—

(40768804) Tissue Pathology biopsy report

213

0.53

1.25

2.0

1.9

—

(3019902) Methicillin resistant Staphylococcus aureus [Presence] in Specimen by Organism specific culture

2.09

1.24

6.0

3.0

—

(3015736) pH of Urine

209

1.63

1.17

4.3

3.2

—

(3037467) Urinalysis macro (dipstick) panel - Urine

371

1.61

1.17

4.3

4.0

—

(586526) SARS-CoV-2 (COVID-19) RNA [Presence] in Nasopharynx by NAA with probe detection

2.38

1.14

2.4

1.3

—

(40758558) Short blood count panel - Blood

132

1.70

1.12

3.6

7.2

—

(3002582) Erythrocytes [#/volume] in Urine

186

1.60

1.07

3.0

2.5

116.16

59.01

e6/l

0.22

146

(46236098) ABO and Rh group [Type] in Blood by Confirmatory method

126

1.68

1.04

2.6

—

(36304419) Bacteria [Presence] in Urine

162

1.60

1.00

3.1

2.5

—

(3020961) Endomysium IgA Ab [Titer] in Serum

0.00

0.99

0.0

1.0

—

(3018095) Leukocytes [#/volume] in Urine

217

1.54

0.98

3.1

2.9

343.10

24.62

e6/l

0.45

153

(3001019) Free T4 and TSH panel - Serum or Plasma

0.00

0.97

0.0

1.6

—

(3022313) Gas panel - Capillary blood

2.24

0.94

7.8

1.8

—

(3012516) Albumin [Mass/volume] in Urine

141

1.57

0.86

2.1

3.2

13.20

76.65

mg/l

—

(4010399)

1.74

0.81

1.3

1.5

—

(3039443) Prostate specific Ag panel - Serum or Plasma

0.00

0.80

0.0

1.6

—

(3000494) Fungus identified in Specimen by Culture

1.75

0.80

1.5

1.8

—

(3027273) Bicarbonate [Moles/volume] in Venous blood

2.16

0.76

4.0

5.0

26.46

24.47

mmol/l

—

(46237023) Hepatitis B virus core and surface Ab and surface Ag panel - Serum

2.16

0.76

1.4

1.3

—

(3020682) Albumin/Creatinine [Ratio] in Urine

147

1.49

0.71

2.5

4.2

1.97

12.20

mg/mmol

—

(40761535) Cells panel - Urine sediment

1.69

0.69

2.9

3.4

—

(3019832) Treponema pallidum Ab [Presence] in Serum

1.63

0.63

1.5

1.6

—

(3017766) Complement C4 [Mass/volume] in Serum or Plasma

0.00

0.60

0.0

1.3

—

0.25

—

(3021589) Normoblasts [#/volume] in Blood

255

1.36

0.60

13.3

9.4

0.00

e9/l

0.50

208

(3000620) Complement C3 [Mass/volume] in Serum or Plasma

0.00

0.59

0.0

1.3

—

1.21

—

(3020460) C reactive protein [Mass/volume] in Serum or Plasma

603

1.54

0.59

25.6

13.1

22.49

24.36

mg/l

0.21

466

(3020059) Calcium [Moles/volume] corrected for albumin in Serum or Plasma

1.50

0.55

2.2

2.7

2.46

2.45

mmol/l

—

(3019284) Hepatitis B virus surface Ag [Presence] in Serum

1.48

0.52

2.0

1.7

—

(3018251) Fasting glucose [Moles/volume] in Serum or Plasma

564

1.41

0.51

4.9

4.2

5.88

5.93

mmol/l

0.12

523

(3044889) 12 lead EKG panel

410

1.31

0.48

4.8

3.8

—

(40761511) CBC panel - Blood by Automated count

634

1.48

0.48

26.0

12.1

—

(3041096) Erythrocytes [Presence] in Urine by Automated

142

1.35

0.44

4.3

3.0

—

(3016251) Hemoglobin.gastrointestinal [Presence] in Stool

1.60

0.43

1.8

2.0

—

(3009201) Thyrotropin [Units/volume] in Serum or Plasma

523

0.78

0.42

4.1

4.2

1.90

1.89

mu/l

0.02

478

(3023150) Myeloperoxidase Ab [Units/volume] in Serum

0.00

0.41

0.0

1.7

—

(3004383) Neutrophil cytoplasmic Ab.classic [Titer] in Serum by Immunofluorescence

0.00

0.41

0.0

1.3

—

(4034850)

0.00

0.39

0.0

13.4

—

(3017143) Hepatitis C virus Ab [Presence] in Serum

1.40

0.36

1.8

1.7

—

(3029187) Natriuretic peptide.B prohormone N-Terminal [Mass/volume] in Serum or Plasma

147

1.29

0.35

3.3

3.1

2232.08

1208.53

ng/l

0.27

124

(3000492) Spirometry study

1.24

0.28

1.4

1.3

—

(3001308) Cholesterol in LDL [Moles/volume] in Serum or Plasma

607

0.81

0.25

4.5

2.65

2.78

mmol/l

0.44

560

(3019550) Sodium [Moles/volume] in Serum or Plasma

604

1.25

0.24

30.2

15.7

139.32

139.65

mmol/l

0.37

590

(3004588) Protein electrophoresis panel - Serum or Plasma

1.27

0.23

1.2

2.8

—

(36660697) Celiac disease serology panel - Serum

1.23

0.22

1.0

1.2

—

(3003191) Choriogonadotropin (pregnancy test) [Presence] in Serum or Plasma

0.00

0.21

0.0

2.0

—

(3030408) 3-Methoxytyramine [Moles/volume] in Serum or Plasma

0.00

0.21

0.0

1.1

—

(1175715) Chlamydophila pneumoniae IgM Ab [Presence] in Serum by Immunoassay

0.00

0.21

0.0

1.3

—

(3017354) Segmented neutrophils/100 leukocytes in Blood

0.00

0.21

0.0

1.8

—

69.80

—

(3032155) Metanephrine Free [Moles/volume] in Serum or Plasma

0.00

0.21

0.0

1.1

—

(1761482) Bacteria [#/volume] in Urine by Culture

0.00

0.21

0.0

4.0

—

(3047007) Chlamydophila sp Ab [Presence] in Serum

0.00

0.21

0.0

1.1

—

(3018387) Mycoplasma pneumoniae IgG Ab [Units/volume] in Serum

0.00

0.21

0.0

1.2

—

(40768793) Breast Pathology biopsy report

0.00

0.21

0.0

1.1

—

(40760888) Immunoglobulin light chains.free panel - Serum

0.00

0.21

0.0

3.5

—

(4035726)

1.27

0.21

1.0

1.3

—

(40768800) Prostate Pathology biopsy report

0.00

0.20

0.0

1.1

—

(3019900) Cholesterol [Moles/volume] in Serum or Plasma

593

0.84

0.19

4.0

4.2

4.49

4.61

mmol/l

0.36

553

(3013512) EKG study

148

1.19

0.19

3.9

3.7

—

(3002385) Erythrocyte distribution width [Ratio]

506

1.16

0.18

29.7

16.6

13.88

13.55

1.19

498

(3002256) Pathology report gross observation

0.72

0.17

1.0

1.2

—

(3023103) Potassium [Moles/volume] in Serum or Plasma

609

1.20

0.17

30.1

15.6

3.98

3.99

mmol/l

0.05

594

(3003694) ABO and Rh group [Type] in Blood

178

1.17

0.17

1.4

—

(3023602) Cholesterol in HDL [Moles/volume] in Serum or Plasma

591

0.86

0.16

3.7

4.1

1.36

1.37

mmol/l

0.05

546

(40768797) Stomach Pathology biopsy report

0.75

0.16

1.0

1.3

—

(43054903) Holo-transcobalamin II [Moles/volume] in Serum

190

1.15

0.15

2.2

2.0

85.96

97.49

pmol/l

0.49

(3009542) Hematocrit [Volume Fraction] of Blood

563

1.13

0.11

26.0

14.4

40.81

41.14

0.16

433

(706163) SARS-CoV-2 (COVID-19) RNA [Presence] in Respiratory system specimen by NAA with probe detection

403

1.09

0.10

3.5

2.9

—

(3004248) Sex hormone binding globulin [Moles/volume] in Serum or Plasma

1.07

0.09

2.4

1.7

28.40

38.23

nmol/l

—

(40760892) CBC W Ordered Manual Differential panel - Blood

136

1.13

0.09

4.4

5.5

—

(3033319) Streptococcus pyogenes Ag [Presence] in Throat

1.06

0.09

1.5

1.3

—

(3036481) Cortisol [Moles/volume] in Serum or Plasma

1.04

0.08

4.2

1.5

434.17

400.57

nmol/l

—

(42868674) Cholesterol in HDL/Cholesterol.total [Molar ratio] in Serum or Plasma

0.78

0.08

3.0

5.0

31.60

30.69

—

(3003510) Neisseria gonorrhoeae DNA [Presence] in Urine by NAA with probe detection

0.82

0.08

1.7

2.0

—

(46235355) HIV 1 and 2 tests - Meaningful Use set

118

1.12

0.07

2.2

2.0

—

(3024135) Streptococcus.beta-hemolytic [Presence] in Throat by Organism specific culture

100

1.12

0.05

1.3

1.4

—

(3026493) Urate [Moles/volume] in Serum or Plasma

142

0.98

0.00

1.4

2.6

381.29

5015.13

umol/l

0.78

119

(3048773) Triglyceride [Moles/volume] in Serum or Plasma --fasting

575

0.97

0.00

3.3

3.8

1.37

1.34

mmol/l

0.15

534

(40764999) Glomerular filtration rate/1.73 sq M.predicted [Volume Rate/Area] in Serum, Plasma or Blood by Creatinine-based formula (CKD-EPI)

554

0.97

0.00

21.0

11.6

85.26

86.79

ml/min/173m2

0.16

458

(3001784) Prostate Specific Ag Free/Prostate specific Ag.total in Serum or Plasma

216

1.03

0.00

4.0

27.37

21.57

—

(3041354) Potassium [Moles/volume] in Venous blood

0.00

0.0

3.6

—

4.07

—

(3044927) Protein electrophoresis panel - Urine

0.00

0.0

1.1

—

(3026389) Candida sp identified in Specimen by Organism specific culture

0.00

0.0

1.1

—

(3024522) Salmonella sp identified in Specimen by Organism specific culture

0.00

0.0

2.0

—

(3035285) Chloride [Moles/volume] in Venous blood

0.00

0.0

3.6

—

107.29

—

(3013201) Beta-2-Microglobulin [Mass/volume] in Serum or Plasma

0.00

0.0

2.0

—

3.34

—

(3005570) Glucose [Moles/volume] in Urine

0.00

0.0

2.4

—

(40762485) Glomerular basement membrane Ab [Units/volume] in Serum by Immunoassay

0.00

0.0

1.1

—

(3004616) Nuclear Ab [Presence] in Serum

0.00

0.0

1.1

—

(40760847) Basement membrane Ab [Titer] in Serum by Immunofluorescence

0.00

0.0

1.4

—

(3038177) Helicobacter pylori Ab [Presence] in Serum

0.00

0.0

1.0

—

(3033705) Calcium.ionized [Moles/volume] in Venous blood

0.00

0.0

3.6

—

(3023410) Appearance of Cerebral spinal fluid

0.00

0.0

2.4

—

(21493466) Plesiomonas shigelloides DNA [Presence] in Stool by NAA with non-probe detection

0.00

0.0

2.0

—

(3025468) Yersinia sp identified in Specimen by Organism specific culture

0.00

0.0

2.0

—

(3012568) Campylobacter sp identified in Specimen by Organism specific culture

0.00

0.0

2.0

—

(21494670) JAK2 gene exon 14 targeted mutation analysis in Blood or Tissue by Molecular genetics method

0.00

0.0

1.1

—

(3005988) Vibrio sp identified in Specimen by Organism specific culture

0.00

0.0

2.0

—

(42868716) Shigella species+EIEC invasion plasmid antigen H ipaH gene [Presence] in Stool by NAA with probe detection

0.00

0.0

2.0

—

(3021952) Alkaline phosphatase isoenzymes [Enzymatic activity/volume] in Serum or Plasma by Heat stability

0.00

0.0

1.6

—

(3012447) Hantavirus puumala IgG Ab [Titer] in Serum

0.00

0.0

1.0

—

(3032699) Streptococcus pneumoniae DNA [Presence] in Specimen by NAA with probe detection

0.00

0.0

1.6

—

(3008037) Lactate [Moles/volume] in Venous blood

0.00

0.0

3.6

—

1.60

—

(3046896) Herpes virus 6 DNA [Presence] in Cerebral spinal fluid by NAA with probe detection

0.00

0.0

1.2

—

(3008757) Leukocyte morphology finding [Identifier] in Blood

0.00

0.0

2.7

—

(3016894) Varicella zoster virus DNA [Presence] in Cerebral spinal fluid by NAA with probe detection

0.00

0.0

1.2

—

(3020876) Protein [Mass/time] in 24 hour Urine

0.00

0.0

2.0

—

(3029075) Extractable nuclear Ab panel - Serum

0.00

0.0

1.0

—

(3035637) Corticotropin [Mass/volume] in Plasma

0.00

0.0

1.1

—

(3012202) Varicella zoster virus DNA [Presence] in Specimen by NAA with probe detection

0.00

0.0

1.0

—

(3027544) Mycobacterium sp identified in Sputum by Organism specific culture

0.00

0.0

3.0

—

(3003245) Complement C1 esterase inhibitor [Mass/volume] in Serum or Plasma

0.00

0.0

1.0

—

0.30

—

(3043405) Microscopic observation [Identifier] in Specimen by Non-gynecological cytology method

0.00

0.0

1.8

—

(3025018) Bordetella pertussis Ab [Titer] in Serum

0.00

0.0

1.0

—

(44816808) CXCL13 Ag [Mass/volume] in Cerebral spinal fluid

0.00

0.0

1.0

—

(21494434) Karyotype in Bone marrow

0.00

0.0

1.0

—

(3041145) Herpes simplex virus IgM Ab [Presence] in Serum by Immunoassay

0.00

0.0

1.0

—

(3030429) Borrelia sp DNA [Identifier] in Specimen by NAA with probe detection

0.00

0.0

1.0

—

(21494890) Protein electrophoresis panel - 24 hour Urine

0.00

0.0

4.9

—

(3037875) Bordetella parapertussis DNA [Presence] in Specimen by NAA with probe detection

0.00

0.0

1.2

—

(3007847) Interleukin 2 Receptor Soluble [Units/volume] in Serum or Plasma

0.00

0.0

1.5

—

469.33

—

(3051611) Lipemic interference index of Serum or Plasma

0.00

0.0

3.3

—

(3022145) Colonoscopy Study observation

0.86

0.00

1.2

1.3

—

(3009340) Metanephrine [Moles/volume] in Serum or Plasma

0.00

0.0

1.0

—

(3011363) Streptococcus pneumoniae Ag [Presence] in Urine

0.00

0.0

1.0

—

(3024950) Chlamydia trachomatis DNA [Presence] in Urine by NAA with probe detection

0.89

0.00

1.7

2.3

—

(3032773) Endomysium IgG Ab [Titer] in Serum

0.00

0.0

1.0

—

(40768795) Lymph node Pathology biopsy report

0.00

0.0

1.0

—

(3000855) Microscopic observation [Identifier] in Vaginal fluid by Gram stain

0.00

0.0

1.4

—

(3019601) Blood group antibody investigation [Interpretation] in Plasma or RBC

0.00

0.0

1.4

—

(3038515) Glucose [Moles/volume] in Venous blood

0.00

0.0

3.6

—

8.60

—

(43055361) Metamyelocytes/Leukocytes [Pure number fraction] in Blood by Manual count

0.00

0.0

2.5

—

(42868544) Hantavirus puumala IgM Ab [Presence] in Serum or Plasma by Immunofluorescence

0.00

0.0

1.0

—

(3004915) Chlamydophila pneumoniae IgA Ab [Units/volume] in Serum

0.00

0.0

1.2

—

(3006442) Creatine [Moles/volume] in Serum or Plasma

0.00

0.0

1.4

—

(42529200) Cancer Ag 15-3 [Units/volume] in Serum or Plasma by Immunoassay

0.00

0.0

2.7

—

164.12

—

(1617658) Protocol used for examination of sentinel lymph nodes

0.00

0.0

1.0

—

Mortality – FinRegistry

↥

This endpoint is excluded from FinRegistry analyses (omitted endpoint).

Relationships between endpoints

↥

Index endpoint: ST19_FROST_INVOLVI_MULTIPLE_BODY_REGIONS_UNSPE_FROST – Frostbite involving multiple body regions and unspecified frostbite

GWS hits: -

This endpoint is excluded from FinRegistry analyses (omitted endpoint).

≡ Risteys

FG R12 + FR

FinnGen R11 + FinRegistry

FinnGen R10 + FinRegistry

FinnGen R10

FinnGen R9

FinnGen R8

FinnGen R7

FinnGen R6

FinnGen R5

FinnGen R4

FinnGen R3

Frostbite involving multiple body regions and unspecified frostbite

Endpoint definition

Endpoint definition steps

FinnGen

Phenotype data

1. Apply sex-specific rule

2. Check conditions

3. Check pre-conditions, main-only, mode, registry filters

4. Check minimum number of events

5. Include endpoints

6. Filter based on genotype QC (FinnGen only)

All original rules

Similar endpoints

Case counts by codes

Upset plot

Case counts by code for Frostbite involving multiple body regions and unspecified frostbite (ST19_FROST_INVOLVI_MULTIPLE_BODY_REGIONS_UNSPE_FROST)

Summary Statistics

-FinRegistry-

-FinnGen-

Key figures

-FinnGen-

Age distribution of first events

-FinnGen-

Year distribution of first events

-FinnGen-

Cumulative Incidence Function

CodeWAS (R11)

Matched cohort

LabWAS

Mortality – FinRegistry

Relationships between endpoints